Citius Oncology, Inc. (CTOR) - Latest Market Data

Price & Market Data

Price: $0.879

Daily Change: -$0.0252 / 2.87%

Daily Range: $0.847 - $0.907

Market Cap: $79,738,984

Daily Volume: 51,742

Performance Metrics

1 Week: -5.60%

1 Month: 32.88%

3 Months: -20.06%

6 Months: -35.48%

1 Year: 1.14%

YTD: -9.67%

About Citius Oncology, Inc. (CTOR)

Up-to-date insights on Citius Oncology, Inc. (CTOR). Current price: 0.879, daily change: -$0.0252 / 2.87%. Market cap: 79,738,984. Performance from 1-month to 1-year.

Details

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. is a subsidiary of Leonard-Meron Biosciences, Inc.

Selected stocks

Bright Minds Biosciences Inc. (DRUG)

Northern Trust Corporation - Depositary Shares Each Representing a 1/1,000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock (NTRSO)

Dine Brands Global, Inc. Common Stock (DIN)

EVgo Inc. (EVGO)

Credit Suisse High Yield Credit Fund (DHY)